159 related articles for article (PubMed ID: 7538906)
21. Expression of CD44 in human lung tumors.
Penno MB; August JT; Baylin SB; Mabry M; Linnoila RI; Lee VS; Croteau D; Yang XL; Rosada C
Cancer Res; 1994 Mar; 54(5):1381-7. PubMed ID: 7509720
[TBL] [Abstract][Full Text] [Related]
22. The CD44 adhesion molecule and metastasis.
Tanabe KK; Saya H
Crit Rev Oncog; 1994; 5(2-3):201-12. PubMed ID: 7531501
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
[TBL] [Abstract][Full Text] [Related]
24. H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells.
Labarrière N; Piau JP; Otry C; Denis M; Lustenberger P; Meflah K; Le Pendu J
Cancer Res; 1994 Dec; 54(23):6275-81. PubMed ID: 7525057
[TBL] [Abstract][Full Text] [Related]
25. Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity.
van Muijen GN; Danen EH; Veerkamp JH; Ruiter DJ; Lesley J; van den Heuvel LP
Int J Cancer; 1995 Apr; 61(2):241-8. PubMed ID: 7535756
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
27. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells.
Jamal HH; Cano-Gauci DF; Buick RN; Filmus J
Oncogene; 1994 Feb; 9(2):417-23. PubMed ID: 7507229
[TBL] [Abstract][Full Text] [Related]
28. Modulation of adenovirus transformation by thyroid hormone.
Fisher PB; Guernsey DL; Weinstein IB; Edelman IS
Proc Natl Acad Sci U S A; 1983 Jan; 80(1):196-200. PubMed ID: 6296867
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells.
Chiao C; Carothers AM; Grunberger D; Solomon G; Preston GA; Barrett JC
Cancer Res; 1995 Aug; 55(16):3576-83. PubMed ID: 7543016
[TBL] [Abstract][Full Text] [Related]
30. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
[TBL] [Abstract][Full Text] [Related]
31. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the E1a gene of type 5 adenovirus result in oncogenic transformation of Fischer rat embryo cells.
Duigou GJ; Babiss LE; Liaw WS; Zimmer SG; Ginsberg HS; Fisher PB
J Cell Biochem; 1987 Feb; 33(2):117-26. PubMed ID: 3571338
[TBL] [Abstract][Full Text] [Related]
33. [CD44, the hyaluronic acid cell receptor. Its role in neoplastic invasion and metastatic dissemination].
Thomas L
Bull Cancer; 1993 Oct; 80(10):833-44. PubMed ID: 7515731
[TBL] [Abstract][Full Text] [Related]
34. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.
Bartolazzi A; Peach R; Aruffo A; Stamenkovic I
J Exp Med; 1994 Jul; 180(1):53-66. PubMed ID: 7516417
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation.
Hall CL; Yang B; Yang X; Zhang S; Turley M; Samuel S; Lange LA; Wang C; Curpen GD; Savani RC; Greenberg AH; Turley EA
Cell; 1995 Jul; 82(1):19-26. PubMed ID: 7541721
[TBL] [Abstract][Full Text] [Related]
37. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
38. Regulation of thyroidal inducibility of Na,K-ATPase and binding of epidermal growth factor in wild-type and cold-sensitive E1a mutant type 5 adenovirus-transformed CREF cells.
Guernsey DL; Duigou GJ; Babiss LE; Fisher PB
J Cell Physiol; 1987 Dec; 133(3):507-14. PubMed ID: 2826499
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
Lokeshwar BL; Lokeshwar VB; Block NL
Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44.
Birch M; Mitchell S; Hart IR
Cancer Res; 1991 Dec; 51(24):6660-7. PubMed ID: 1742741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
